PRESS RELEASE published on 08/19/2025 at 06:59, 9 months 5 days ago Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for the full-year
BRIEF published on 07/30/2025 at 10:04, 9 months 24 days ago Medartis présentera ses résultats semestriels 2025 en webcast Résultats Semestriels Webcast Dispositifs Médicaux Medartis Séance De Questions-réponses
BRIEF published on 07/30/2025 at 10:04, 9 months 24 days ago Medartis to Present 2025 Half-Year Results in Webcast Medical Devices Webcast Half-year Results Q&A Session Medartis
PRESS RELEASE published on 07/30/2025 at 09:59, 9 months 24 days ago Medartis 2025 half-year results webcast Medartis Holding AG to present 2025 half-year results via webcast on August 19, 2025. CEO Matthias Schupp and CFO Dirk Kirsten to speak. Event details and registration link provided Webcast Medartis Holding AG Dirk Kirsten Matthias Schupp 2025 Half-Year Results
BRIEF published on 07/17/2025 at 07:04, 10 months 7 days ago Medartis finalise l'acquisition complète de KeriMedical Approbation De La FDA KeriMedical Acquisition De Medartis Remplacement Articulaire Prothèse TOUCH
BRIEF published on 07/17/2025 at 07:04, 10 months 7 days ago Medartis Finalizes Full Acquisition of KeriMedical FDA Approval Medartis Acquisition KeriMedical Joint Replacement TOUCH Prosthesis
PRESS RELEASE published on 07/17/2025 at 06:59, 10 months 7 days ago Medartis acquires remaining 53% stake in KeriMedical Medartis acquires remaining 53% stake in KeriMedical, strengthening position in joint replacement & expanding surgeon network. Acquisition valued at CHF 99 million in cash with FDA-approved flagship product TOUCH Acquisition FDA Approval Medartis KeriMedical Joint Replacement
PRESS RELEASE published on 03/18/2025 at 06:59, 1 year 2 months ago Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19%
PRESS RELEASE published on 08/20/2024 at 07:05, 1 year 9 months ago Medartis reports 13% revenue growth on Group level, driven by strong regional growth in the US (21%) and EMEA (18%) –improvement of EBITDA* margin to 17%
BRIEF published on 07/09/2024 at 07:04, 1 year 10 months ago Matthias Schupp nommé PDG de Medartis Technologie Médicale Nomination Du PDG Medartis Matthias Schupp
Published on 05/23/2026 at 19:45, 13 hours 28 minutes ago Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 1 day 5 hours ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 1 day 6 hours ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 1 day 6 hours ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 1 day 6 hours ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/24/2026 at 05:55, 3 hours 17 minutes ago The 26th CIFIT to Open in Xiamen This September, Preceded by Successful Guangzhou Roadshow
Published on 05/24/2026 at 05:35, 3 hours 37 minutes ago CGTN: Xizang at 75: Development and culture create a 'miracle on Earth'
Published on 05/23/2026 at 16:30, 16 hours 42 minutes ago HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 17 hours 16 minutes ago EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 1 day 11 hours ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 19:35, 1 day 13 hours ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day 15 hours ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day 15 hours ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 20 hours ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 20 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
